Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,747 | 128,249 | 118,697 | 107,611 | 111,209 |
| Receivables | 68,380 | 66,036 | 9,969 | 5,823 | 4,877 |
| Inventories | 8,544 | 7,902 | 1,813 | 1,401 | 1,520 |
| TOTAL | $216,293 | $207,713 | $133,484 | $118,896 | $120,615 |
| Non-Current Assets | |||||
| PPE Net | 3,203 | 1,612 | 1,826 | 1,632 | 1,583 |
| Intangibles | 453,694 | 486,100 | 0 | 1,877 | 1,925 |
| Other Non-Current Assets | 139 | 853 | 258 | 268 | 392 |
| TOTAL | $457,036 | $488,565 | $2,084 | $3,777 | $3,900 |
| Total Assets | $673,329 | $696,278 | $135,568 | $122,673 | $124,515 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 114,825 | 131,056 | 1,479 | 2,146 | 2,389 |
| Accounts payable and accrued liabilities | 18,692 | 9,336 | 5,684 | 4,982 | 5,612 |
| Accrued Expenses | 131,185 | 109,836 | 24,325 | 19,268 | 10,199 |
| TOTAL | $264,702 | $250,228 | $31,488 | $26,396 | $28,561 |
| Non-Current Liabilities | |||||
| Long Term Debt | 325,946 | 355,227 | N/A | 0 | 424 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 10,361 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 8 | 17 |
| TOTAL | $325,946 | $355,227 | $N/A | $8 | $441 |
| Total Liabilities | $590,648 | $605,455 | $31,488 | $26,404 | $29,002 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,222 | 33,044 | 32,994 | 32,562 | 29,567 |
| Common Shares | 33 | 33 | 33 | 31 | 30 |
| Retained earnings | -329,761 | -316,701 | -298,049 | -280,646 | -267,383 |
| TOTAL | $82,681 | $90,823 | $104,080 | $96,269 | $95,513 |
| Total Liabilities And Equity | $673,329 | $696,278 | $135,568 | $122,673 | $124,515 |